These were prolonged QTc intervals [89], gastric lesions, and lower esophageal sphincter and pyloric sphincter dysfunction induced by dopamine receptor antagonists [68,92,165,172], as well as gastric lesions induced by combined application of dopamine receptor antagonist and reserpine [166]
Ensuring Approval for Weight Loss Medication Getting the green light for weight loss medication from Blue Cross Blue Shield involves a few key steps
Our firm is currently investigating Saxenda lawsuits involving a diagnosis of: Gastroparesis/stomach paralysis Gastrointestinal obstruction/ileus Blindness and/or vision problems (NAION) Daily vomiting lasting at least 3 weeks Blood clots/deep vein thrombosis (DVT) or pulmonary embolism (PE) Affected individuals are encouraged to contact our office to discuss their legal options
Blood 140 , 15331548 (2022)
For frequent international travelers, consider keeping a laminated card with your medication information in multiple languages
doi: 10.2165/00151829-200504030-00003